Radiopharmaceuticals are rapidly evolving, and RDC (Radionuclide Drug Conjugate), as a member of them, are receiving lots of attention. An in-depth understanding of binding interactions between targeted molecules and ligand is crucial to elucidating binding mechanisms and stability during the RDC development.
Rdcthera have set up an excellent RDC analysis platform and standard procedures to provide cost-effective and customized complement radioligand binding analysis service for global clients.
There are no reviews for this PDF.
There are no comments for this PDF.
You must log in to post a comment.
Log in
